CONMED Corp
CNMDCIK 0000816956 · Electromedical & Electrotherapeutic Apparatus · NYSE
Revenue (TTM)
$1.32B
+5.2% YoY
FY Feb 2026
Net Income (TTM)
$79.3M
−64.5% YoY
FY Feb 2026
EPS Diluted (TTM)
$2.54
−64.5% YoY
FY Feb 2026
Gross Margin
54.0%
FY Feb 2026
Operating Margin
10.0%
FY Feb 2026
Net Margin
6.0%
FY Feb 2026
Free Cash Flow (TTM)
$53.38M
FY Feb 2026
Cash
$25.86M
FY Feb 2026
Total Debt
$794.17M
FY Feb 2026
Shares Outstanding
30.83M sh
FY Feb 2026
Revenue & Net Income
EPS (Diluted)
Margins
Cash Flow
Revenue Growth (YoY)
Balance Sheet
Cash vs Debt
Latest news
All news →-
Low Neutral
CONMED Appoints John Gallagher as CFO, Effective July 15
The medical-device maker hired an experienced healthcare finance executive from Certara to replace Todd Garner.